Related Experiment Video
Updated: Oct 18, 2025

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
Defective myelination in an RNA polymerase III mutant leukodystrophic mouse
Emilio Merheb1, Min-Hui Cui2,3, Juwen C DuBois4
1Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461.
Abstract:
RNA polymerase (Pol) III synthesizes abundant short noncoding RNAs that have essential functions in protein synthesis, secretion, and other processes. Despite the ubiquitous functions of these RNAs, mutations in Pol III subunits cause Pol III-related leukodystrophy, an early-onset neurodegenerative disease. The basis of this neural sensitivity and the mechanisms of disease pathogenesis are unknown. Here we show that mice expressing pathogenic mutations in the largest Pol III subunit, Polr3a, specifically in Olig2-expressing cells, have impaired growth and developmental delay, deficits in cognitive, sensory, and fine sensorimotor function, and hypomyelination in multiple regions of the cerebrum and spinal cord. These phenotypes reflect a subset of clinical features seen in patients. In contrast, the gross motor defects and cerebellar hypomyelination that are common features of severely affected patients are absent in the mice, suggesting a relatively mild form of the disease in this conditional model. Our results show that disease pathogenesis in the mice involves defects that reduce both the number of mature myelinating oligodendrocytes and the ability of these cells to produce a myelin sheath of normal thickness. The findings suggest unique sensitivities of oligodendrogenesis and myelination to perturbations of Pol III transcription.
Insights
Mutations in RNA polymerase III (Pol III) cause neurodegenerative disease. Mice with Pol III gene mutations in specific brain cells show developmental delays and hypomyelination, revealing insights into leukodystrophy pathogenesis.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- RNA polymerase III (Pol III) synthesizes vital short noncoding RNAs.
- Mutations in Pol III subunits lead to Pol III-related leukodystrophy, a severe early-onset neurodegenerative disease.
- The neural basis and disease mechanisms remain poorly understood.
Purpose of the Study:
- To investigate the role of Pol III in neural development and disease.
- To model Pol III-related leukodystrophy using conditional mouse mutants.
Main Methods:
- Generated mice with pathogenic mutations in the largest Pol III subunit (Polr3a) specifically in Olig2-expressing cells.
- Assessed growth, development, cognitive, sensory, and sensorimotor functions.
- Examined myelination in the cerebrum and spinal cord.
Main Results:
- Conditional mice exhibited impaired growth, developmental delay, and functional deficits.
- Hypomyelination was observed in multiple brain and spinal cord regions.
- Oligodendrocyte development and myelin sheath formation were impaired.
Conclusions:
- Perturbations in Pol III transcription uniquely affect oligodendrogenesis and myelination.
- This study provides a conditional model for understanding Pol III-related leukodystrophy.
- The findings highlight the critical role of Pol III in maintaining neural health and myelin integrity.

